Markus Absenger
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Pollution top 10%
- Microplastics and Plastic Pollution
Papers in
-
- Graphene and Nanomaterials Applications 2
- 3D Printing in Biomedical Research 2
- Co-authors
- Eleonore Fröhlich (6 shared papers)Eva Roblegg (6 shared papers)Andreas Zimmer (3 shared papers)Claudia Meindl (3 shared papers)Gerd Leitinger (3 shared papers)Birgit Johanna Teubl (2 shared papers)Thomas R. Pieber (2 shared papers)Birgit Ebner (2 shared papers)
In The Last Decade
Markus Absenger
14 papers receiving 740 citations
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 124
- Pollution 84
- Obstetrics and Gynecology 47
- Biomaterials 80
- Cancer Research 66
Countries citing papers authored by Markus Absenger
This map shows the geographic impact of Markus Absenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Absenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Absenger more than expected).
Fields of papers citing papers by Markus Absenger
This network shows the impact of papers produced by Markus Absenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Absenger. The network helps show where Markus Absenger may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Absenger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 137 | |
| 2 | 2009 | 95 | |
| 3 | 2012 | 92 | |
| 4 | 2013 | 81 | |
| 5 | 2012 | 80 | |
| 6 | 2013 | 70 | |
| 7 | 2013 | 60 | |
| 8 | 2013 | 44 | |
| 9 | Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling. | 2014 | 27 |
| 10 | 2014 | 27 | |
| 11 | 2013 | 18 | |
| 12 | The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT. | 2015 | 13 |
| 13 | 2014 | 3 | |
| 14 | Flow-Driven Loading of Living Cells with Impermeable Fluorescent Molecules | 2007 | 2 |
About Markus Absenger
Markus Absenger is a scholar working on Molecular Biology, Biomedical Engineering, Materials Chemistry, Pollution and Pharmaceutical Science, having authored 14 papers that have together received 749 indexed citations. Recurring topics across this work include Nanoparticles: synthesis and applications (3 papers), Microplastics and Plastic Pollution (2 papers), Graphene and Nanomaterials Applications (2 papers), Drug Solubulity and Delivery Systems (2 papers), Advanced Drug Delivery Systems (2 papers), MicroRNA in disease regulation (2 papers), 3D Printing in Biomedical Research (2 papers) and Neuroscience and Neural Engineering (1 paper). The work is most often cited by research in Pharmaceutical Science (124 citations), Pollution (84 citations), Obstetrics and Gynecology (47 citations), Biomaterials (80 citations) and Cancer Research (66 citations). Markus Absenger has collaborated with scholars based in Austria and Germany. Frequent co-authors include Eleonore Fröhlich, Eva Roblegg, Andreas Zimmer, Claudia Meindl, Gerd Leitinger, Birgit Johanna Teubl, Thomas R. Pieber, Birgit Ebner, Christa Schimpel and Beate Rinner. Their work appears in journals such as PLoS ONE, Molecular Pharmaceutics, Particle and Fibre Toxicology, BioMed Research International and Journal of Neurotrauma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.